新芝生物
(920685)
| 流通市值：6.78亿 | | | 总市值：10.63亿 |
| 流通股本：5831.40万 | | | 总股本：9151.60万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 83,854,158.79 | 34,891,531.29 | 169,724,864.23 | 114,171,509.27 |
| 营业总成本 | 68,876,287.87 | 29,363,681.61 | 129,940,626.36 | 92,159,963.11 |
| 其他经营收益 | | | | |
| 营业利润 | 20,882,834.23 | 8,806,570.53 | 48,951,172.5 | 29,349,016.05 |
| 利润总额 | 20,741,550.06 | 8,812,218.71 | 48,665,496.29 | 29,329,008.05 |
| 净利润 | 18,829,136.88 | 8,279,181.27 | 43,699,136.64 | 26,833,139.98 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 18,829,136.88 | 8,279,181.27 | 43,699,136.64 | 26,833,139.98 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 419,416,165.56 | 409,357,608.68 | 422,129,130.44 | 403,769,203.13 |
| 非流动资产: | | | | |
| 非流动资产合计 | 259,093,698.91 | 257,149,592.27 | 258,444,755.19 | 253,558,213.84 |
| 资产总计 | 678,509,864.47 | 666,507,200.95 | 680,573,885.63 | 657,327,416.97 |
| 流动负债: | | | | |
| 流动负债合计 | 82,371,311.33 | 68,463,533.58 | 77,311,794.57 | 73,093,947.47 |
| 非流动负债: | | | | |
| 非流动负债合计 | 4,553,907.59 | 5,082,668.94 | 5,913,607.24 | 3,750,982.34 |
| 负债合计 | 86,925,218.92 | 73,546,202.52 | 83,225,401.81 | 76,844,929.81 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 561,682,863.51 | 565,373,066.84 | 558,415,234.93 | 543,919,609.59 |
| 股东权益合计 | 591,584,645.55 | 592,960,998.43 | 597,348,483.82 | 580,482,487.16 |
| 负债和股东权益合计 | 678,509,864.47 | 666,507,200.95 | 680,573,885.63 | 657,327,416.97 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 100,930,850.65 | 44,678,989.31 | 215,077,607.39 | 140,051,945.72 |
| 经营活动现金流出小计 | 107,141,609.65 | 57,934,358.79 | 153,946,506.77 | 117,510,692.67 |
| 经营活动产生的现金流量净额 | -6,210,759 | -13,255,369.48 | 61,131,100.62 | 22,541,253.05 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 431,878,114.06 | 111,997,202.9 | 888,902,180.23 | 823,868,316.54 |
| 投资活动现金流出小计 | 421,035,781.77 | 76,936,990.02 | 920,672,216.41 | 837,848,821.36 |
| 投资活动产生的现金流量净额 | 10,842,332.29 | 35,060,212.88 | -31,770,036.18 | -13,980,504.82 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 25,915,264.21 | 13,706,238.95 | 28,037,879.08 | 27,138,452.12 |
| 筹资活动产生的现金流量净额 | -25,915,264.21 | -13,706,238.95 | -28,037,879.08 | -27,138,452.12 |
| 汇率变动对现金及现金等价物的影响 | -472,097.42 | -226,855.21 | -177,192.74 | -20,443.69 |
| 现金及现金等价物净增加额 | -21,755,788.34 | 7,871,749.24 | 1,145,992.62 | -18,598,147.58 |
| 期末现金及现金等价物余额 | 74,830,127.16 | 104,457,664.74 | 96,585,915.5 | 76,841,775.3 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -21,755,788.34 | - | 1,145,992.62 | - |